MEDINET Co., Ltd. (2370.T)
JPY 37.0
(0.0%)
JPY 37.0
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 98.25 Million JPY | -23.2% |
| 2022 | 127.92 Million JPY | -29.09% |
| 2021 | 180.41 Million JPY | -38.08% |
| 2020 | 291.37 Million JPY | -27.24% |
| 2019 | 400.43 Million JPY | 21.34% |
| 2018 | 330.01 Million JPY | -57.09% |
| 2017 | 769.11 Million JPY | -10.64% |
| 2016 | 860.67 Million JPY | 27.88% |
| 2015 | 673.03 Million JPY | -18.48% |
| 2014 | 825.6 Million JPY | -19.51% |
| 2013 | 1.02 Billion JPY | -11.0% |
| 2012 | 1.15 Billion JPY | -31.41% |
| 2011 | 1.68 Billion JPY | -22.69% |
| 2010 | 2.17 Billion JPY | 7.67% |
| 2009 | 2.01 Billion JPY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | 28.31 Million JPY | 1284.55% |
| 2024 Q2 | 2.04 Million JPY | -97.32% |
| 2024 Q1 | 76.39 Million JPY | 170.91% |
| 2023 Q4 | 28.19 Million JPY | 1355.06% |
| 2023 FY | 98.25 Million JPY | -23.2% |
| 2023 Q2 | 21.86 Million JPY | -52.72% |
| 2023 Q3 | 1.93 Million JPY | -91.14% |
| 2023 Q1 | 46.24 Million JPY | 21.07% |
| 2022 FY | 127.92 Million JPY | -29.09% |
| 2022 Q4 | 38.19 Million JPY | 80.84% |
| 2022 Q2 | 28.77 Million JPY | -27.76% |
| 2022 Q1 | 39.83 Million JPY | -1.17% |
| 2022 Q3 | 21.12 Million JPY | -26.58% |
| 2021 Q3 | 90.46 Million JPY | 224.41% |
| 2021 Q1 | 21.76 Million JPY | -47.96% |
| 2021 Q2 | 27.88 Million JPY | 28.12% |
| 2021 Q4 | 40.3 Million JPY | -55.45% |
| 2021 FY | 180.41 Million JPY | -38.08% |
| 2020 FY | 291.37 Million JPY | -27.24% |
| 2020 Q4 | 41.82 Million JPY | 112.88% |
| 2020 Q1 | 142.43 Million JPY | 0.73% |
| 2020 Q2 | 87.46 Million JPY | -38.59% |
| 2020 Q3 | 19.64 Million JPY | -77.54% |
| 2019 Q1 | 78.63 Million JPY | 21.03% |
| 2019 Q3 | 81.85 Million JPY | -16.94% |
| 2019 Q4 | 141.4 Million JPY | 72.75% |
| 2019 FY | 400.43 Million JPY | 21.34% |
| 2019 Q2 | 98.54 Million JPY | 25.32% |
| 2018 Q2 | 86.2 Million JPY | -25.75% |
| 2018 Q3 | 62.73 Million JPY | -27.22% |
| 2018 FY | 330.01 Million JPY | -57.09% |
| 2018 Q1 | 116.1 Million JPY | -35.6% |
| 2018 Q4 | 64.97 Million JPY | 3.56% |
| 2017 Q1 | 191.51 Million JPY | -21.73% |
| 2017 FY | 769.11 Million JPY | -10.64% |
| 2017 Q2 | 204.43 Million JPY | 6.75% |
| 2017 Q4 | 180.28 Million JPY | -6.53% |
| 2017 Q3 | 192.88 Million JPY | -5.65% |
| 2016 Q4 | 244.69 Million JPY | 12.06% |
| 2016 Q1 | 181.2 Million JPY | 15.74% |
| 2016 Q2 | 216.42 Million JPY | 19.43% |
| 2016 Q3 | 218.35 Million JPY | 0.89% |
| 2016 FY | 860.67 Million JPY | 27.88% |
| 2015 FY | 673.03 Million JPY | -18.48% |
| 2015 Q2 | 229.32 Million JPY | 56.1% |
| 2015 Q4 | 156.56 Million JPY | 11.64% |
| 2015 Q3 | 140.23 Million JPY | -38.85% |
| 2015 Q1 | 146.91 Million JPY | -11.47% |
| 2014 Q2 | 234.28 Million JPY | -11.46% |
| 2014 FY | 825.6 Million JPY | -19.51% |
| 2014 Q4 | 165.93 Million JPY | 3.21% |
| 2014 Q3 | 160.77 Million JPY | -31.37% |
| 2014 Q1 | 264.6 Million JPY | -2.67% |
| 2013 Q2 | 239.52 Million JPY | -0.6% |
| 2013 Q3 | 273.32 Million JPY | 14.11% |
| 2013 Q4 | 271.87 Million JPY | -0.53% |
| 2013 FY | 1.02 Billion JPY | -11.0% |
| 2013 Q1 | 240.97 Million JPY | -10.24% |
| 2012 Q3 | 269.89 Million JPY | -15.89% |
| 2012 Q1 | 293.3 Million JPY | -24.63% |
| 2012 FY | 1.15 Billion JPY | -31.41% |
| 2012 Q2 | 320.86 Million JPY | 9.4% |
| 2012 Q4 | 268.47 Million JPY | -0.52% |
| 2011 FY | 1.68 Billion JPY | -22.69% |
| 2011 Q3 | 383.6 Million JPY | -7.96% |
| 2011 Q2 | 416.78 Million JPY | -15.06% |
| 2011 Q4 | 389.14 Million JPY | 1.44% |
| 2011 Q1 | 490.68 Million JPY | -10.76% |
| 2010 Q3 | 516.52 Million JPY | -7.1% |
| 2010 Q1 | 550.88 Million JPY | -11.5% |
| 2010 FY | 2.17 Billion JPY | 7.67% |
| 2010 Q4 | 549.87 Million JPY | 6.46% |
| 2010 Q2 | 556.01 Million JPY | 0.93% |
| 2009 Q4 | 622.49 Million JPY | 10.48% |
| 2009 Q2 | 422.37 Million JPY | 2.99% |
| 2009 FY | 2.01 Billion JPY | 0.0% |
| 2009 Q1 | 410.09 Million JPY | 0.0% |
| 2009 Q3 | 563.42 Million JPY | 33.4% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 1.88 Billion JPY | 94.777% |
| PRISM BioLab Co.,LTD | 80.3 Million JPY | -22.347% |
| GNI Group Ltd. | 22.43 Billion JPY | 99.562% |
| Linical Co., Ltd. | 3.77 Billion JPY | 97.4% |
| Trans Genic Inc. | 2.24 Billion JPY | 95.632% |
| Soiken Holdings Inc. | 2.48 Billion JPY | 96.042% |
| Cytori Cell Research Institute, Inc. | 1.29 Billion JPY | 92.399% |
| AnGes, Inc. | -3.06 Billion JPY | 103.205% |
| OncoTherapy Science, Inc. | -177.71 Million JPY | 155.285% |
| Nxera Pharma Co., Ltd. | 9.66 Billion JPY | 98.983% |
| Immuno-Biological Laboratories Co., Ltd. | 517.29 Million JPY | 81.007% |
| NanoCarrier Co., Ltd. | 110.95 Million JPY | 11.45% |
| Carna Biosciences, Inc. | 1.45 Billion JPY | 93.227% |
| CanBas Co., Ltd. | -984 Million JPY | 109.985% |
| D. Western Therapeutics Institute, Inc. | 391.69 Million JPY | 74.916% |
| RaQualia Pharma Inc. | 1.65 Billion JPY | 94.067% |
| Chiome Bioscience Inc. | 398.59 Million JPY | 75.35% |
| Kidswell Bio Corporation | 1.03 Billion JPY | 90.547% |
| PeptiDream Inc. | 17.21 Billion JPY | 99.429% |
| Oncolys BioPharma Inc. | 30.6 Million JPY | -221.033% |
| Ribomic Inc. | -10.5 Million JPY | 1035.555% |
| SanBio Company Limited | -14.5 Million JPY | 777.413% |
| Healios K.K. | 108 Million JPY | 9.026% |
| BrightPath Biotherapeutics Co., Ltd. | -341 Thousand JPY | 28912.903% |
| Kubota Pharmaceutical Holdings Co., Ltd. | -59.04 Million JPY | 266.399% |
| Delta-Fly Pharma, Inc. | -1.51 Million JPY | 6598.148% |
| StemRIM | -44.34 Million JPY | 321.543% |
| CellSource Co., Ltd. | 3.18 Billion JPY | 96.915% |
| FunPep Company Limited | -680.28 Million JPY | 114.443% |
| Kringle Pharma, Inc. | 69.25 Million JPY | -41.88% |
| Stella Pharma Corporation | 217.29 Million JPY | 54.785% |
| TMS Co., Ltd. | -6.95 Million JPY | 1513.698% |
| Noile-Immune Biotech Inc. | 314.56 Million JPY | 68.765% |
| Cuorips Inc. | 9.63 Million JPY | -920.164% |
| K Pharma,Inc. | 910 Million JPY | 89.203% |
| Takara Bio Inc. | 25.45 Billion JPY | 99.614% |
| ReproCELL Incorporated | 1.1 Billion JPY | 91.106% |
| PhoenixBio Co., Ltd. | 1.19 Billion JPY | 91.778% |
| StemCell Institute Inc. | 1.57 Billion JPY | 93.765% |
| Japan Tissue Engineering Co., Ltd. | 1.66 Billion JPY | 94.105% |
| CellSeed Inc. | 107.15 Million JPY | 8.309% |